{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:30Z","timestamp":1791389550712,"version":"4.3.3"},"reference-count":24,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v103.5578","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T12:19:38Z","timestamp":1680610778000},"page":"adv5578","source":"Crossref","is-referenced-by-count":17,"title":["Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review"],"prefix":"10.2340","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7277-9787","authenticated-orcid":false,"given":"Dianhe","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9799-8625","authenticated-orcid":false,"given":"Yunqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"30294","doi-asserted-by":"crossref","unstructured":"Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol 2020; 82: 675-682.","DOI":"10.1016\/j.jaad.2019.08.032"},{"key":"30295","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.032","DOI":"10.1016\/j.jaad.2019.08.032"},{"key":"30296","doi-asserted-by":"crossref","unstructured":"Andersen YM, Egeberg A, Gislason GH, Skov L, Thyssen JP. Autoimmune diseases in adults with atopic dermatitis. J Am Acad Dermatol 2017; 76: 274-280.e1.","DOI":"10.1016\/j.jaad.2016.08.047"},{"key":"30297","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2016.08.047","DOI":"10.1016\/j.jaad.2016.08.047"},{"key":"30298","doi-asserted-by":"crossref","unstructured":"Barton VR, Toussi A, Awasthi S, Kiuru M. Treatment of pediatric alopecia areata: a systematic review. J Am Acad Dermatol 2022; 86: 1318-1334.","DOI":"10.1016\/j.jaad.2021.04.077"},{"key":"30299","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2021.04.077","DOI":"10.1016\/j.jaad.2021.04.077"},{"key":"30300","doi-asserted-by":"crossref","unstructured":"Lensing M, Jabbari A. An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata. Front Immunol 2022; 13: 955035.","DOI":"10.3389\/fimmu.2022.955035"},{"key":"30301","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fimmu.2022.955035","DOI":"10.3389\/fimmu.2022.955035"},{"key":"30302","doi-asserted-by":"crossref","unstructured":"King B, Ko J, Forman S, Ohyama M, Mesinkovska N, Yu G, et al. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: phase 2 results from a randomized controlled study. J Am Acad Dermatol 2021; 85: 847-853.","DOI":"10.1016\/j.jaad.2021.05.050"},{"key":"30303","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2021.05.050","DOI":"10.1016\/j.jaad.2021.05.050"},{"key":"30304","doi-asserted-by":"crossref","unstructured":"King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, et al. Two phase 3 trials of baricitinib for alopecia areata. N Engl J Med 2022; 386: 1687-1699.","DOI":"10.1056\/NEJMoa2110343"},{"key":"30305","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa2110343","DOI":"10.1056\/NEJMoa2110343"},{"key":"30306","doi-asserted-by":"crossref","unstructured":"Craiglow BG, King BA. Tofacitinib for the treatment of alopecia areata in preadolescent children. J Am Acad Dermatol 2019; 80: 568-570.","DOI":"10.1016\/j.jaad.2018.08.041"},{"key":"30307","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2018.08.041","DOI":"10.1016\/j.jaad.2018.08.041"},{"key":"30308","doi-asserted-by":"crossref","unstructured":"Asfour L, Getsos Colla T, Moussa A, Sinclair RD. Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib. Int J Dermatol 2022; 61: e416-e417.","DOI":"10.1111\/ijd.16316"},{"key":"30309","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ijd.16316","DOI":"10.1111\/ijd.16316"},{"key":"30310","doi-asserted-by":"crossref","unstructured":"Cantelli M, Martora F, Patruno C, Nappa P, Fabbrocini G, Napolitano M. Upadacitinib improved alopecia areata in a patient with atopic dermatitis: a case report. Dermatol Ther 2022; 35: e15346.","DOI":"10.1111\/dth.15346"},{"key":"30311","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/dth.15346","DOI":"10.1111\/dth.15346"},{"key":"30312","doi-asserted-by":"crossref","unstructured":"Gambardella A, Licata G, Calabrese G, De Rosa A, Alfano R, Argenziano G. Dual Efficacy of upadacitinib in 2 patients with concomitant severe atopic dermatitis and alopecia areata. Dermatitis 2021; 32: e85-e86.","DOI":"10.1097\/DER.0000000000000780"},{"key":"30313","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/DER.0000000000000780","DOI":"10.1097\/DER.0000000000000780"},{"key":"30314","doi-asserted-by":"crossref","unstructured":"Gori N, Cappilli S, Di Stefani A, Tassone F, Chiricozzi A, Peris K. Assessment of alopecia areata universalis successfully treated with upadacitinib. Int J Dermatol 2023; 62: e61-e63.","DOI":"10.1111\/ijd.16342"},{"key":"30315","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ijd.16342","DOI":"10.1111\/ijd.16342"},{"key":"30316","doi-asserted-by":"crossref","unstructured":"Le M, Berman-Rosa M, Ghazawi FM, Bourcier M, Fiorillo L, Gooderham M, et al. Systematic review on the efficacy and safety of oral janus kinase inhibitors for the treatment of atopic dermatitis. Front Med (Lausanne) 2021; 8: 682547.","DOI":"10.3389\/fmed.2021.682547"},{"key":"30317","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fmed.2021.682547","DOI":"10.3389\/fmed.2021.682547"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/5578\/15934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/5578\/15934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T12:20:16Z","timestamp":1680610816000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/5578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2340\/actadv.v103.5578","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}